AccuVein
Private Company
Total funding raised: $139.5M
Overview
AccuVein is a U.S.-based, private medical device company founded in 2006, specializing in non-invasive vein visualization technology. Its core product line uses patented near-infrared imaging and True Center™ laser alignment to help healthcare professionals locate veins, valves, and bifurcations not visible to the naked eye. The technology is positioned to address significant clinical and operational challenges in vascular access across acute, non-acute, and aesthetic care settings, with demonstrated benefits in procedure speed, first-stick success, and cost reduction. The company has iterated through multiple product generations, with the AV600 representing its latest commercial offering.
Technology Platform
Near-infrared (NIR) light-based vein visualization with patented True Center™ laser alignment technology for real-time projection of superficial vasculature onto the skin.
Funding History
7Opportunities
Risk Factors
Competitive Landscape
AccuVein competes in the vein visualization market against companies like Christie Medical Holdings (VeinViewer), Venoscope, and other regional players. Its key differentiators are its patented, permanently aligned True Center™ technology (no calibration) and its Class 1 laser designation. The competitive landscape is defined by continuous innovation in image clarity, ergonomics, and integration into clinical workflows.